Medical Condition News

RSS

Non-invasive breath analysis could improve treatment of malignant pleural mesothelioma

Identifying and analyzing volatile organic compounds in exhaled breath of patients with malignant pleural mesothelioma showed promise as a screening method for MPM, according to research presented today at the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer in Singapore.

11 Sep 2023

Understanding the impact of aphantasia on visual mental imagery and visual perception

The ability to visualize faces, objects, landscapes, or even scenes from the past exists on a spectrum. While some can picture the layout of a city in minute detail and mentally walk through it, street by street, others have a perfectly blank internal cinema.

11 Sep 2023

Exploring the anti-cancer potential of dark tea

The potential of dark tea in cancer prevention and management.

11 Sep 2023

Color of the phlegm can indicate degree of lung inflammation in patients with bronchiectasis

The color of the phlegm from patients with the lung disease bronchiectasis can indicate the degree of inflammation in their lungs and predict their future outcomes, according to new research presented at the European Respiratory Society International Congress in Milan, Italy.

11 Sep 2023

Can fluctuating reproductive hormone levels cause mental health conditions?

The association between mental health and fluctuations in reproductive hormone levels.

11 Sep 2023

Dietary cholesterol and fruit tannins synergistically promote kidney stone formation

Kidney stones (KS), hard crystalline formations that occur within the kidney, are a common condition that affects millions of people worldwide.

11 Sep 2023

Unlocking the secret drivers of deadly pancreatic cancer: New target offers hope for treatment

Researchers identify a super-enhancer-regulated RNA-binding protein cascade that drives the growth of pancreatic ductal adenocarcinoma, a deadly form of pancreatic cancer. The discovery offers a promising new avenue for targeted therapy, potentially sidestepping severe side effects associated with other treatments.

10 Sep 2023

Mediterranean diet supercharges skin treatment, clears up atopic dermatitis in teen

Study reports on a 14-year-old boy with atopic dermatitis who experienced complete symptom resolution after combining monoclonal antibody treatment with a Mediterranean diet. Highlighting the role of diet in managing inflammatory skin conditions, the case study suggests the therapeutic potential of integrating dietary changes with medical treatment for improved outcomes.

10 Sep 2023

Unlocking the genetic code of blood sugar reveals new diabetes risks and lung complications

The study used a genome-wide association study (GWAS) to analyze random glucose levels in nearly half a million non-diabetic subjects, uncovering 150 distinct genetic signals, including 53 new ones, linked to glycemic traits and type 2 diabetes. The research also discovered a causal effect of random glucose and type 2 diabetes on lung function, identifying lung dysfunction as a new diabetes complication.

10 Sep 2023

Is DNA methylation the missing link in diagnosing and treating psoriasis and psoriatic arthritis?

Researchers across Europe have delved into the DNA methylation patterns in CD4+ T-cells of psoriasis and psoriatic arthritis (PsA) patients, unveiling potential new biomarkers for these conditions. Their study suggests that these unique profiles could serve as both diagnostic and prognostic tools, although further validation is needed for real-world clinical application.

10 Sep 2023

Study could pave the way to new treatments for people with compromised immune systems

New research led by Queen’s University Belfast has made a breakthrough in the field of microbiology, which could lead to the development of new treatments for people with compromised immune systems, such as those with cystic fibrosis.

9 Sep 2023

Breakthrough trial may improve diagnosis and life outcomes for patients with high-risk myeloma

Findings from a new medical trial, recently published in a prestigious scientific journal, may significantly improve life outcomes for patients with high-risk myeloma.

9 Sep 2023

Study evaluating intranasal anti-CD3 for treatment of Alzheimer’s disease published in the PNAS journal

Tiziana Life Sciences Ltd. (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced acceptance of a publication, “Nasal Administration of anti-CD3 monoclonal antibody (mAb) ameliorates disease in a mouse model of Alzheimer’s disease”, in the preeminent journal, Proceedings of the National Academy of Sciences (PNAS), that supports foralumab’s mechanism as a potential treatment for Alzheimer’s disease (AD), a difficult-to-treat neuroinflammatory disease.

9 Sep 2023

University of Birmingham and Acticor Biotech announce MHRA approval of LIBERATE clinical study

September 7th, 2023, the University of Birmingham and Acticor Biotech announce the full regulatory approval of LIBERATE clinical study.

9 Sep 2023

Evaluating the efficacy of third dose booster vaccine against SARS-CoV-2 in patients with cancer

A new editorial paper was published in Oncoscience (Volume 10) on September 1, 2023, entitled, "Exiting the pandemic together: achieving global immunity and equity."

8 Sep 2023

Irisin-based therapies may help combat Alzheimer’s disease

Researchers who previously developed the first 3D human cell culture models of Alzheimer's disease (AD) that displays two major hallmarks of the condition - the generation of amyloid beta deposits followed by tau tangles - have now used their model to investigate whether the exercise-induced muscle hormone irisin affects amyloid beta pathology.

8 Sep 2023

BBRF hosts a free webinar on a precision-health approach to bipolar disorder

The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, "A Precision-Health Approach to Bipolar Disorder" on Tuesday, September 12, 2023, at 2:00 pm EST.

8 Sep 2023

Research review focuses on the use of psilocybin for treatment of depression

A growing body of evidence suggests that psychedelic drugs may be useful in treating various mental health conditions.

8 Sep 2023

New way to administer CAR-T-cell therapy could lead to fewer side effects

When Richard O'Neil, Ph.D., joined MUSC Hollings Cancer Center two years ago, he knew that he wanted to continue finding ways to make CAR-T-cell therapy easier on patients.

8 Sep 2023

Capture and release of tumor cells using a bioelectronic device

In the book entitled Microfluidic Systems for Cancer Diagnosis, the UPV/EHU’s Microfluidics Cluster group describes the process for building a bioelectronic device consisting of gold electrodes coated with a smart polymer capable of capturing and releasing cells in a non-invasive, controllable way while monitoring the processes using conventional electrical measurements.

8 Sep 2023

Medical Condition News

Non-invasive breath analysis could improve treatment of malignant pleural mesothelioma

Understanding the impact of aphantasia on visual mental imagery and visual perception

Exploring the anti-cancer potential of dark tea

Color of the phlegm can indicate degree of lung inflammation in patients with bronchiectasis

Can fluctuating reproductive hormone levels cause mental health conditions?

Dietary cholesterol and fruit tannins synergistically promote kidney stone formation

Unlocking the secret drivers of deadly pancreatic cancer: New target offers hope for treatment

Mediterranean diet supercharges skin treatment, clears up atopic dermatitis in teen

Unlocking the genetic code of blood sugar reveals new diabetes risks and lung complications

Is DNA methylation the missing link in diagnosing and treating psoriasis and psoriatic arthritis?

Study could pave the way to new treatments for people with compromised immune systems

Breakthrough trial may improve diagnosis and life outcomes for patients with high-risk myeloma

Study evaluating intranasal anti-CD3 for treatment of Alzheimer’s disease published in the PNAS journal

University of Birmingham and Acticor Biotech announce MHRA approval of LIBERATE clinical study

Evaluating the efficacy of third dose booster vaccine against SARS-CoV-2 in patients with cancer

Irisin-based therapies may help combat Alzheimer’s disease

BBRF hosts a free webinar on a precision-health approach to bipolar disorder

Research review focuses on the use of psilocybin for treatment of depression

New way to administer CAR-T-cell therapy could lead to fewer side effects

Capture and release of tumor cells using a bioelectronic device

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News